Calendrier des promotions Bioqual Inc
Calendrier avancé
Graphique simple
À propos de l'entreprise Bioqual Inc
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.Paramètres de base
ISIN
US09065J1016
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0.7407
Дивиденд ао
0.5
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 1.11 | 9 |
P/BV | 1.72 | 8 |
P/E | 134.12 | 1 |
Efficacité
Nom | Signification | Grade |
ROA | 0.8201 | 1 |
ROE | 1.28 | 1 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0.7407 | 1.85 |
DSI | 0.8571 | 8.57 |
Croissance moyenne du dividende | 0.0249 | 0.04 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | 1.18 | 8 |
Debt/Ratio | 0.0634 | 10 |
Debt/Equity | 0.503 | 9 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | 26.38 | 4 |
Rentabilité Ebitda, % | -68.41 | 0 |
Rentabilité EPS, % | -89.18 | 0 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 44.25 $ | 0 $ | 0 $ | 9.81 % | 0 % | 0 % |
common.calendar.number_days.7d | 44.25 $ | 0 $ | 0 $ | 9.81 % | 0 % | 0 % |
common.calendar.number_days.30d | 45 $ | 44.25 $ | 48.59 $ | 7.98 % | 0 % | 0 % |
common.calendar.number_days.90d | 55 $ | 44.25 $ | 56 $ | -11.65 % | 0 % | 0 % |
common.calendar.number_days.180d | 60 $ | 44.25 $ | 65 $ | -19.02 % | 0 % | 0 % |
common.calendar.number_days.1y | 70 $ | 44.25 $ | 72.5 $ | -30.59 % | 0 % | 0 % |
common.calendar.number_days.3y | 35 $ | 44.25 $ | 104 $ | 38.83 % | 0 % | 0 % |
common.calendar.number_days.5y | 44.25 $ | 44.25 $ | 108.5 $ | 100 % | 0 % | 0 % |
common.calendar.number_days.10y | 14 $ | 14 $ | 108.5 $ | 316.07 % | 0 % | 0 % |
common.calendar.number_days.ytd | 60 $ | 44.25 $ | 65 $ | -19.02 % | 0 % | 0 % |
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Dr. Mark G. Lewis Ph.D. | Chairman of the Board, CEO & President | 1955 (70 années) | |
Mr. Charles C. Kirk Jr., CPA | Chief Financial Officer | ||
Mitch Franklin | Chief Operating Officer | ||
Ms. Hanne Andersen-Elyard Ph.D. | Chief Scientific Officer |
Informations sur l'entreprise
Adresse: United States, Rockville, 9600 Medical Center Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.bioqual.com
Site web: https://www.bioqual.com